Central Nervous System Lymphoma

general

A non-Hodgkin or Hodgkin lymphoma that arises from the brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis.

Centers

Active Trials

$1.3B

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Secondary Central Nervous System Lymphoma (SCNSL)	11	12

Top Centers for Central Nervous System Lymphoma(30)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center	High-Volume Research Center	4	$46K	87.7
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
4	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
5	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	53.4
6	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	2	—	53.4
7	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	2	—	53.4
8	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
9	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	53.4
10	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
11	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	2	—	53.4
12	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	53.4
13	University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer CenterBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
14	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
15	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	53.4
16	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	1	—	53.4
17	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	53.4
18	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	1	—	53.4
19	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	53.4
20	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	1	—	53.4
21	Princess Margaret Cancer CentreToronto, ON Active Research Program	Active Research Program	1	—	53.4
22	Sandra and Edward Meyer Cancer Center at Weill Cornell MedicineNew York, NY Active Research Program	Active Research Program	—	$3M	50.6
23	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	—	$2M	49.2
24	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	—	31.7
25	OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive		—	—	31.7
26	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	—	31.7
27	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		1	$737M	—
28	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		1	$319M	—
29	Cleveland Clinic Cancer CenterCleveland, OH		1	$150M	—
30	University of Cincinnati Cancer CenterCincinnati, OH		1	$71M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →